280 likes | 405 Views
New treatment options for use in bipolar mania. Dr C Verster Dept Psychiatry Uuniversity of Stellenbosch. The Mind is its own place and in itself can make a Heaven a Hell, a Hell a Heaven. John Milton. Normal Mood. HIGH. LOW. Unipolar Depression (The Common Garden Variety). HIGH.
E N D
New treatment options for use in bipolar mania Dr C Verster Dept Psychiatry Uuniversity of Stellenbosch
The Mind is its own place and in itself can make a Heaven a Hell, a Hell a Heaven John Milton
Normal Mood HIGH LOW
Bipolar (II) Disorder HIGH LOW
Bipolar (I) Disorder MANIA HIGH LOW
Trying to describe bipolar disorder “The cogs of my mind are not all working together”
Case study • 32yr old female patient (Pt AB) • Going through divorce; 1 child (4yrs old) • Working as secretary • Known with diagnosis of Bipolar I Disorder • On medication: Lithium 750mg at night • Progressively less sleep x 2 weeks • Irritability++
On day of evaluation: • Grandiose • Refusing medication • Refusing to go to work • “Don’t need psychiatrist” • Praying to random people in the street • Giving away money • Family “at wits’ end” • “This is the 3rd such episode in 18 months” • “She will lose her child” • “Employer is fed-up”
What now? • Admission • She refuses • Family unable to deal with her • Irresponsible behaviour (child’s safety) • Danger to self / reputation
Approach to Patient with acute manic relapse • Admission • Sedation • Stabilization • Prevention of relapse
Admission Pt AB: Needs admission ?Involuntary - certified • MHCA • Voluntary • Involuntary
Sedation Pt AB: Lorazepam IMI OR Olanzepine/ Ziprasidone IMI (NB Avoid IMI Benzo/Olanzepine combination) • Benzodiazepines • Oral/Sublingual • IMI/IVI • Antipsychotics (IMI) • Zuclopenthixol decanoate • Olanzapine IMI • Ziprasidone IMI • Haloperidol IMI • Clothiapine IMI
Stabilization • Behaviour / Sleep / Psychosis / Mood
Bowden (2002): A drug that • benefits at least one primary aspect of bipolar illness • is effective in both acute and maintenance phases • does not worsen any aspect of the illness Traditional mood stabilizers: • lithium, valproate, carbamazepine (recently: lamotrigine) • Stahl 2010: • Includes atypical antipsychotics • Antipsychotics always used in mania • Atypicals also have effect on bipolar depression • (Antidepressants = mood destabilizers)
FDA Approved Bipolar Treatment Regimens: Gutman DA, Nemeroff C. Atypical Antipsychotics in Bipolar Disorder. Medscape. Available at http://www.medscape.com/viewarticle/554128. Accessed June 27, 2007
2011 (Sachs et al; J Clin Psych) Category A evidence (Double blind placebo controlled trials; adequate sample) Efficacy for acute mania: Lithium Valproate Carbamazepine Olanzapine Risperidone Ziprasidone Haloperidol Quetiapine Aripirazole Paliperidone Asenapine
Lithium Pt AB: No use as sedative Why did she relapse? Why did she refuse medication? May still be of use in long term management • Used since the 1950’s • Effective mood stabilizer • Narrow therapeutic range (Blood levels monitored) • Toxicity • Acute • Chronic • Thyroid • Kidneys
Anti Epileptics Pt AB: Limited efficacy in mania Side effect profile Pregnancy? • Carbamazepine / Valproate / Lamotrigine
Antipsychotics • Typicals • Haloperidol • Zuclopenthixol • Chlorpromazine • Effective, but poor side-effect profile
Why maintenance therapy? • Prevention of relapse • ±80% relapse within 1 year without medication • ±20% relapse within 1 year with medication • In practice: ±50% relapse within 1st year • Because of poor treatment adherence
Cost of relapse • Hospitalization (may be for weeks) • R700-2000 per day • PMB • Social & occupational consequences
Reason for poor adherence • Poor psychoeducation • Lack of insight • Poor understanding of illness • Side-effects • Cost factors • Social pressure/stigma • Dosage interval / amount of tablets • Religious / cultural factors • Availability of medication • Substance abuse • Severity of illness
Stabilization/Maintenance Stahl, SM. The Prescriber’s Guide 3rd ed; 2009
Pt AB • Stabilize! • Psychoeducation – also family! • Lithium levels → discontinue or not? • Monotherapy or combination? • Illness profile • Sleeping pattern • Depressive episodes? • Cost factors